PMEDF Predictmedix Inc.

Predictmedix, Inc. engages in the development of cannabis derived products. Its subsidiaries are in the early stage marijuana services and products, development of cosmetic and edible product lines, as well as investment in technology to detect if an individual is under the influence of cannabis and to predict substance addiction. The company was founded on September 3, 1987 and is headquartered in Toronto, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.10    OTCQB
As of 01/21/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Medical Devices
Index country:  Canada
Country of incorporation:  
IPO date:  04/03/2020
Outstanding shares:  108,801,292
Average volume:  50,364
Market cap:   $12,044,303
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -12.87
PB ratio:   7.69
PS ratio:   120.11
Return on equity:   -131.43%
Net income %:   -1,887.08%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy